Patent: 7,196,054
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 7,196,054
| Title: | Methods for treating wound tissue and forming a supplemented fibrin matrix |
| Abstract: | This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one antimicrobial composition. The composition may be further supplemented with, for example, one or more antibodies, analgesics, anticoagulants, antiproliferatives, anti-inflammatory compounds, cytokines, cytotoxins, drugs, growth factors, interferons, hormones, lipids, demineralized bone or bone morphogenetic proteins, cartilage inducing factors, oligonucleotides polymers, polysaccharides, polypeptides, protease inhibitors, vasoconstrictors or vasodilators, vitamins, minerals, stabilizers and the like. |
| Inventor(s): | Drohan; William N. (Springfield, VA), MacPhee; Martin J. (Darnestown, MD), Nunez; Hernan (Derwood, MD), Liau; Gene (Wayland, MA), Maciag; Thomas (Portland, ME), Burgess; Wilson H. (Clifton, VA) |
| Assignee: | The American National Red Cross (Rockville, MD) |
| Application Number: | 08/485,883 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,196,054
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2024-03-27 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
